<DOC>
	<DOCNO>NCT00263874</DOCNO>
	<brief_summary>This initial proof concept , phase II study aim assess safety efficacy UK-500,001 chronic maintenance treatment adult Chronic Obstructive Pulmonary Disease .</brief_summary>
	<brief_title>Phase 2 Study Safety Efficacy UK-500,001 Adult Patients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Moderatesevere COPD ( Global inititiative chronic Obstructive Lung Disease , GOLD , 2003 definition ) Smoking history least 10 packyears Any significant comorbid disease Use maintenance therapy except short act bronchodilator</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2007</verification_date>
</DOC>